162 related articles for article (PubMed ID: 36192427)
21. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
Xiao J; Liu Y; Yi J; Liu X
Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
[TBL] [Abstract][Full Text] [Related]
22. Increased ANXA5 expression in stomach adenocarcinoma infers a poor prognosis and high level of immune infiltration.
Su Z; Shu K; Li G
Cancer Biomark; 2022; 35(2):155-165. PubMed ID: 35912732
[TBL] [Abstract][Full Text] [Related]
23. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
26. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
27. Identification of long noncoding RNA RP11-169F17.1 and RP11-669N7.2 as novel prognostic biomarkers of stomach adenocarcinoma based on integrated bioinformatics analysis.
Yang J; Song H
Epigenomics; 2019 Aug; 11(11):1307-1321. PubMed ID: 31368349
[No Abstract] [Full Text] [Related]
28. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
29. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
31. Analysis of expression profile of miRNA in stomach adenocarcinoma.
Huo Q
J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
[TBL] [Abstract][Full Text] [Related]
32. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
33. Ferroptosis‑related long non‑coding RNAs and the roles of LASTR in stomach adenocarcinoma.
Wang G; Sun L; Wang S; Guo J; Xiao R; Li W; Qi W; Qiu W
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137922
[TBL] [Abstract][Full Text] [Related]
34. Identification of key long non-coding RNAs in gastric adenocarcinoma.
Fu T; Ji X; Bu Z; Zhang J; Wu X; Zong X; Fan B; Jia Z; Ji J
Cancer Biomark; 2020; 27(4):541-553. PubMed ID: 32176636
[TBL] [Abstract][Full Text] [Related]
35. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma.
Yang H; Tian W; Zhou B
Genomics; 2022 Jan; 114(1):361-377. PubMed ID: 34933074
[TBL] [Abstract][Full Text] [Related]
36. Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas.
Zheng GL; Zhang GJ; Zhao Y; Zheng ZC
Front Oncol; 2022; 12():901182. PubMed ID: 35574353
[TBL] [Abstract][Full Text] [Related]
37. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
Cheng P
J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
39. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]